 Matthew Galbraith
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclin-Dependent Kinase 8 | 7 | 2021 | 38 | 1.850 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 111 | 1.480 |
Why?
| | Interferons | 5 | 2023 | 151 | 1.370 |
Why?
| | Tumor Suppressor Protein p53 | 9 | 2023 | 455 | 1.360 |
Why?
| | Transcriptome | 4 | 2022 | 756 | 1.320 |
Why?
| | Transcription, Genetic | 9 | 2021 | 1323 | 1.300 |
Why?
| | Down Syndrome | 5 | 2023 | 356 | 1.170 |
Why?
| | Transcriptional Activation | 9 | 2023 | 348 | 1.130 |
Why?
| | Mediator Complex | 3 | 2013 | 52 | 0.970 |
Why?
| | Neoplasms | 8 | 2023 | 2179 | 0.840 |
Why?
| | Blood | 1 | 2022 | 100 | 0.820 |
Why?
| | Proteome | 2 | 2022 | 353 | 0.800 |
Why?
| | Seroconversion | 1 | 2021 | 48 | 0.770 |
Why?
| | Genomics | 2 | 2021 | 706 | 0.680 |
Why?
| | RNA Polymerase II | 7 | 2019 | 282 | 0.640 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 1974 | 0.600 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2021 | 246 | 0.570 |
Why?
| | Cell Hypoxia | 2 | 2017 | 220 | 0.570 |
Why?
| | ets-Domain Protein Elk-1 | 2 | 2013 | 14 | 0.560 |
Why?
| | Mitogens | 2 | 2013 | 57 | 0.550 |
Why?
| | Protein Kinase Inhibitors | 2 | 2018 | 811 | 0.540 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 160 | 0.520 |
Why?
| | Serum Response Element | 2 | 2011 | 5 | 0.480 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 20 | 0.460 |
Why?
| | Signal Transduction | 7 | 2023 | 4709 | 0.400 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1158 | 0.380 |
Why?
| | Anemia, Sickle Cell | 2 | 2023 | 230 | 0.370 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2021 | 1167 | 0.310 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 2851 | 0.310 |
Why?
| | Humans | 39 | 2023 | 118974 | 0.310 |
Why?
| | Nuclear Proteins | 4 | 2023 | 597 | 0.310 |
Why?
| | Glutamine | 2 | 2023 | 88 | 0.290 |
Why?
| | Cell Proliferation | 6 | 2023 | 2275 | 0.290 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 289 | 0.270 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 468 | 0.270 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1346 | 0.260 |
Why?
| | Pantoea | 1 | 2004 | 2 | 0.260 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2004 | 5 | 0.260 |
Why?
| | Phenazines | 1 | 2004 | 9 | 0.260 |
Why?
| | Datasets as Topic | 2 | 2022 | 103 | 0.250 |
Why?
| | Apoptosis | 6 | 2023 | 2484 | 0.240 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 15 | 0.240 |
Why?
| | Animals | 15 | 2023 | 33381 | 0.240 |
Why?
| | HCT116 Cells | 3 | 2019 | 68 | 0.240 |
Why?
| | Hypoxia | 3 | 2023 | 963 | 0.240 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.230 |
Why?
| | Fibroblasts | 2 | 2019 | 842 | 0.230 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 15 | 0.230 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2023 | 145 | 0.230 |
Why?
| | Hematopoiesis | 2 | 2021 | 175 | 0.230 |
Why?
| | HeLa Cells | 3 | 2013 | 583 | 0.220 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 135 | 0.210 |
Why?
| | Enteritis | 1 | 2022 | 78 | 0.210 |
Why?
| | Medulloblastoma | 1 | 2023 | 177 | 0.200 |
Why?
| | Transcription Factors | 3 | 2023 | 1570 | 0.200 |
Why?
| | Imidazoles | 2 | 2020 | 232 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 404 | 0.200 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.200 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 210 | 0.200 |
Why?
| | Erythrocytes | 2 | 2023 | 641 | 0.200 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 77 | 0.190 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 146 | 0.190 |
Why?
| | Oncogenes | 1 | 2021 | 111 | 0.190 |
Why?
| | Piperazines | 2 | 2020 | 316 | 0.190 |
Why?
| | RNA Helicases | 1 | 2020 | 20 | 0.180 |
Why?
| | Proteomics | 2 | 2023 | 876 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 253 | 0.180 |
Why?
| | Cell Line | 3 | 2021 | 2707 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 65 | 0.180 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 239 | 0.170 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 191 | 0.160 |
Why?
| | Inpatients | 1 | 2022 | 388 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 296 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2022 | 308 | 0.160 |
Why?
| | Complement Activation | 1 | 2021 | 350 | 0.160 |
Why?
| | Hexokinase | 1 | 2017 | 10 | 0.160 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 11 | 0.160 |
Why?
| | Complement System Proteins | 1 | 2021 | 294 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 397 | 0.160 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 34 | 0.160 |
Why?
| | Deoxyglucose | 1 | 2017 | 46 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2022 | 3171 | 0.150 |
Why?
| | Autoimmunity | 1 | 2023 | 831 | 0.150 |
Why?
| | Homeostasis | 1 | 2021 | 594 | 0.150 |
Why?
| | Mice | 9 | 2023 | 15520 | 0.150 |
Why?
| | Gene Editing | 1 | 2017 | 63 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 371 | 0.150 |
Why?
| | Lysine Acetyltransferase 5 | 1 | 2016 | 2 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 363 | 0.140 |
Why?
| | Osteosarcoma | 1 | 2017 | 71 | 0.140 |
Why?
| | Purines | 1 | 2017 | 161 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 152 | 0.140 |
Why?
| | Acetylation | 2 | 2016 | 217 | 0.140 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 164 | 0.140 |
Why?
| | Glycolysis | 1 | 2017 | 224 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 703 | 0.140 |
Why?
| | Comorbidity | 1 | 2021 | 1527 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2019 | 736 | 0.140 |
Why?
| | Histone Acetyltransferases | 1 | 2016 | 53 | 0.140 |
Why?
| | Conserved Sequence | 1 | 2016 | 219 | 0.130 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 139 | 0.130 |
Why?
| | Tretinoin | 1 | 2016 | 116 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 336 | 0.130 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1510 | 0.130 |
Why?
| | Down-Regulation | 1 | 2017 | 627 | 0.130 |
Why?
| | Bone Neoplasms | 1 | 2017 | 199 | 0.130 |
Why?
| | HEK293 Cells | 2 | 2016 | 625 | 0.130 |
Why?
| | DNA Helicases | 1 | 2016 | 131 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 551 | 0.130 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1059 | 0.130 |
Why?
| | Drosophila Proteins | 1 | 2016 | 171 | 0.120 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 200 | 0.120 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 17 | 0.120 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 16 | 0.120 |
Why?
| | Protein Binding | 4 | 2021 | 1975 | 0.120 |
Why?
| | Phosphorylation | 2 | 2019 | 1633 | 0.120 |
Why?
| | Genes, ras | 1 | 2013 | 95 | 0.120 |
Why?
| | Models, Biological | 1 | 2021 | 1715 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2013 | 64 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 900 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 610 | 0.110 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2012 | 10 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 46 | 0.100 |
Why?
| | Hospitalization | 1 | 2021 | 1785 | 0.100 |
Why?
| | Histones | 2 | 2016 | 552 | 0.100 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 34 | 0.100 |
Why?
| | Gene Silencing | 2 | 2023 | 177 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2016 | 745 | 0.090 |
Why?
| | Biomarkers | 1 | 2021 | 3588 | 0.090 |
Why?
| | Yeasts | 1 | 2010 | 52 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 3 | 2023 | 618 | 0.090 |
Why?
| | Phenotype | 3 | 2023 | 3003 | 0.090 |
Why?
| | MCF-7 Cells | 2 | 2020 | 111 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 13 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2020 | 1965 | 0.080 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 544 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 740 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2023 | 565 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2445 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2019 | 874 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2220 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2023 | 2680 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 62 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 61 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 2004 | 162 | 0.060 |
Why?
| | Hydroxyurea | 1 | 2023 | 30 | 0.060 |
Why?
| | Glutamates | 1 | 2023 | 60 | 0.060 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 18 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 44 | 0.060 |
Why?
| | Proline | 1 | 2023 | 71 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| | Kynurenine | 1 | 2023 | 81 | 0.060 |
Why?
| | Receptors, Interferon | 1 | 2023 | 49 | 0.060 |
Why?
| | Sphingosine | 1 | 2023 | 35 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2004 | 314 | 0.060 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 139 | 0.060 |
Why?
| | Tyrosine | 1 | 2023 | 233 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2021 | 2657 | 0.060 |
Why?
| | Mutation | 1 | 2013 | 3457 | 0.060 |
Why?
| | Lysophospholipids | 1 | 2023 | 68 | 0.050 |
Why?
| | Cyclins | 1 | 2022 | 82 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 174 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 179 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2023 | 1753 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1597 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 755 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 53 | 0.050 |
Why?
| | Clonal Evolution | 1 | 2021 | 26 | 0.050 |
Why?
| | Escherichia coli | 1 | 2004 | 758 | 0.050 |
Why?
| | Polyribosomes | 1 | 2020 | 23 | 0.050 |
Why?
| | Data Mining | 1 | 2021 | 113 | 0.050 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 31 | 0.050 |
Why?
| | BRCA1 Protein | 1 | 2020 | 57 | 0.050 |
Why?
| | Vesiculovirus | 1 | 2019 | 9 | 0.050 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 87 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2871 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 142 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 69 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 387 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 176 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 80 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 33 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 369 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 333 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 842 | 0.040 |
Why?
| | Cell Survival | 1 | 2021 | 1047 | 0.040 |
Why?
| | Up-Regulation | 1 | 2021 | 872 | 0.040 |
Why?
| | Female | 5 | 2023 | 61565 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 574 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 401 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 300 | 0.040 |
Why?
| | Promyelocytic Leukemia Protein | 1 | 2016 | 4 | 0.040 |
Why?
| | Protein Domains | 1 | 2017 | 212 | 0.040 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 2016 | 13 | 0.040 |
Why?
| | Metabolomics | 1 | 2021 | 550 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 23 | 0.040 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 2016 | 11 | 0.040 |
Why?
| | Mitosis | 1 | 2017 | 172 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2016 | 45 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2016 | 35 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2159 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1085 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1206 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 136 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 373 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 211 | 0.030 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2016 | 93 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 333 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 377 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1720 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 460 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2490 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 564 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 3730 | 0.030 |
Why?
| | Monocytes | 1 | 2016 | 513 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 441 | 0.030 |
Why?
| | Caspase 8 | 1 | 2012 | 47 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 671 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 408 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 190 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1224 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3443 | 0.020 |
Why?
| | Protein Transport | 1 | 2012 | 412 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 27617 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 4908 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4596 | 0.020 |
Why?
| | Adult | 2 | 2021 | 31512 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1774 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4077 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2008 | 31 | 0.020 |
Why?
| | Genes, fos | 1 | 2008 | 36 | 0.020 |
Why?
| | RNA | 1 | 2014 | 833 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 200 | 0.020 |
Why?
| | Mitochondria | 1 | 2012 | 786 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10793 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2008 | 580 | 0.020 |
Why?
| | Male | 2 | 2021 | 57801 | 0.020 |
Why?
| | Child | 1 | 2023 | 19129 | 0.020 |
Why?
|
|
Galbraith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|